Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
611
-
Total 13F shares, excl. options
-
72,541,663
-
Shares change
-
+224,471
-
Total reported value, excl. options
-
$25,025,110,595
-
Value change
-
+$77,686,718
-
Put/Call ratio
-
126%
-
Number of buys
-
299
-
Number of sells
-
-264
-
Price
-
$344.99
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2018
721 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2018.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 611 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72,541,663 shares
of 104,986,330 outstanding shares and own 69.1% of the company stock.
Largest 10 shareholders include Capital World Investors (6,062,272 shares), BlackRock Inc. (5,990,839 shares), VANGUARD GROUP INC (5,679,059 shares), WELLINGTON MANAGEMENT GROUP LLP (4,378,479 shares), FMR LLC (4,288,397 shares), LOOMIS SAYLES & CO L P (3,305,142 shares), STATE STREET CORP (3,240,402 shares), HARRIS ASSOCIATES L P (3,148,677 shares), SANDS CAPITAL MANAGEMENT, LLC (2,305,811 shares), and JANUS HENDERSON GROUP PLC (1,802,740 shares).
This table shows the top 611 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.